Jump to content

Phase 3 ENSPIRIT clinical trial in NSCLC


Recommended Posts



The Phase 3 ENSPIRIT clinical trial in NSCLC recently passed an important clinical milestone and is continuing to enroll patients globally. The trial is evaluating the potential of custirsen to improve survival outcomes in patients with advanced or metastatic NSCLC who have progressed after initial chemotherapy treatment has failed. Patients will be randomly selected to receive a second-line standard of care, docetaxel, with or without custirsen therapy. For more information about the trial, speak with your doctor or visit https://clinicaltrials.gov/ct2/show/NCT01630733.

Link to comment
Share on other sites

  • 2 weeks later...

Please let me know what kind of download you are trying to do.  There are several ways to download things.  If you're trying to download something off this message board all you should have to do is click on it and it should automatically download and open but if it doesn't then you'll need to go into your computers settings and check the security and enable downloads.

hope that helps-

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.